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Human papillomavirus (HPV) plays an important role in the 
pathogenesis of cervical cancer.  HPV has been found in 99.7% of 
cervical cancers worldwide.  This common virus is easily transmitted 
by genital skin-to skin and sexual contact.  The HPVs that infect the 
genital mucosa are classified according to their oncogenic potential and 
are described as either high or low-risk.  The detection of E7 oncogene 
transcripts of high-risk human papillomavirus type 16, 18, 31, 33, 35, 
39, 45, 51, 52 and 56 may be a sensitive indicator of the direct 
involvement of viral oncogenes in the development of cervical 
intraepithelial neoplasia and carcinoma.  Three methods were used in 
this study; Type Specific PCR, Dot-blot hybridization to prove no false 
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positive of the TS-PCR products and SyBr Green Real Time PCR to 
detect and identify the multiple infection of the HPV subtypes.  The 
objectives of this study are i) to determine the prevalence and the types 
of human papillomavirus in the neoplastic cervical tissues patients, ii) 
to detect and identify the multiple infections of HPV subtypes. Paraffin 
embedded tissues was collected from Hospital Universiti Kebangsaan 
Malaysia.  All 67 specimens from several stages; Cervical 
intraepithelial neoplasia CIN I, CIN II, CIN III and carcinoma were 
screened for the presence of high risk HPV types.   To determine the 
presence of HPV in the samples, Type Specific PCR (TS-PCR) and dot 
blot hybridization were performed.  Positive samples from the TS-PCR 
and dot blot hybridization were analyzed and identified for the 
presence of the two prevalent HPV genotypes such as HPV 16 and 
HPV 18 using the SyBr Green Real-Time PCR.  The results showed, in 
67 samples, CIN I was detected in 37/67 (55%), CIN II was detected in 
12/67 (18%), CIN III was detected in 15/67 (22%) and in 3/67 (5%) 
patients, invasive carcinoma was found.  Because of the multiple 
infections, 67 HPV genomes were found in the 57 positive samples 
using TS-PCR. HPV 16 genome was detected in 55/67 (82%) cases, 
HPV 18 in 8/67 (12%) cases, HPV 33 was detected in 1/67 (1.5%), HPV 
51 was detected in 1/67 (1.5%) and HPV 56 in 2/67 (3%) and 8 cases 
had multiple infections.  The results showed DNA melting curve for 
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HPV 16 was having a peak around 80.2º ± 0.2C and threshold Ct value 
for specific product of HPV-16 was 20 ± 1 cycles whereas DNA melting 
curve for HPV 18 was having a peak around 79.2 ± 0.2ºC and threshold 
cycle Ct value for specific product of HPV 18 was 22 ± 1 cycles.      
 
In conclusion, HPV- 16 was the most prevalent followed by HPV-18.  
This study detected five subtypes of high risk HPV; HPV 16, 18, 33, 51 
and 56.  HPV types 31, 35, 39, 45 and 52 were not detected.  A SyBr 
Green Real-Time PCR method has the potential for clinical usage in 
prescreening, detection and identification of HPV infection in the 
cervical neoplasia at different stages of the disease. 
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Human papillomavirus (HPV) memainkan peranan penting dalam 
patogenesis kanser servik.  Pengesanan transkrip onkogen E7 terhadap 
HPV risiko tinggi jenis 16, 18, 31, 33, 35, 39, 45, 51, 52 dan 56 
merupakan petunjuk yang sensitif untuk memperlihatkan penglibatan 
onkogen viral dalam pembentukkan neoplasia intraepithelial servik 
dan karsinoma.  Tiga teknik digunakan dalam kajian ini; TS-PCR, dot-
blot hybridization iaitu untuk membuktikan tiada nya positif palsu 
hasil dari TS-PCR dan SyBr Green Real Time PCR.   Objektif kajian 
adalah untuk menentukan prevalen dan jenis-jenis HPV risiko tinggi 
dalam pesakit-pesakit kanser servik di Malaysia, dan untuk mengesan 
dan mengenalpasti jangkitan oleh pelbagai jenis HPV dalam pesakit 
kanser servik.  Spesimen tisu dalam paraffin diperolehi daripada 
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Hospital Universiti Kebangsaan Malaysia (HUKM).  Sebanyak 67 
spesimen dari pelbagai peringkat; Cervical Intraepithelial Neoplasia 
(CIN) I, CIN II, CIN III dan karsinoma telah disaring untuk 
menentukan kehadiran jenis-jenis HPV risiko tinggi.  Untuk mengesan 
kehadiran jenis-jenis HPV dalam sample-sampel, Tindakbalas Berantai 
Polymerase-Jenis Spesifik dan hibridisasi dengan prob spesifik telah 
digunakan.   Dari 67 sampel yang dikaji, 57 sampel telah dikenalpasti 
sebagai positif iaitu sample telah dijangkiti oleh sejenis atau pelbagai 
jenis HPV.  Sampel yang positif sebanyak 57 ini seterusnya dilakukan 
ujian menggunakan Tindakbalas Berantai Polymerase-Masa Sebenar 
untuk mengesan kehadiran jenis-jenis HPV risiko tinggi, seterusnya 
mengesan dan mengenalpasti kehadiran dua jenis HPV genotip yang 
paling prevalen iaitu HPV 16 dan HPV 18. 
 
Keputusan ujikaji menunjukkan daripada 67 sampel yang dikaji, CIN I 
telah dikesan sebanyak 37/67 (55%) kes, CIN II sebanyak 12/67 (18%) 
kes, CIN III sebanyak 15/67 (22%) kes dan 3/67 (5%) kes bagi pesakit 
invasif karsinoma.  Oleh kerana adanya jangkitan oleh pelbagai jenis 
HPV, keputusan keseluruhan menunjukkan 67 jenis HPV genom telah 
ditemui dalam 57 sampel positif daripada teknik Tindakbalas Berantai 
Polymerase-Jenis Spesifik.  Genom HPV 16 telah dikesan sebanyak 
55/67 (82%) kes, genom HPV 18 sebanyak 8/67 (12%) kes, genom HPV 
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33 sebanyak 1/67 (1.5%), genom HPV 51 sebanyak 1/67 (1.5%) dan 
genom HPV 56 sebanyak 2/67 (3%). 
 
Fluorescen SyBrGreen telah diukur bagi setiap amplifikasi dan terbitan 
pertama fluorescen telah diplotkan sebagai fungsi suhu.  Untuk 
membezakan hasil spesifik HPV 16 dan HPV 18, graf pencairan DNA 
telah dilakukan selepas tindakbalas berantai polymerase.  Keputusan 
menunjukkan graf pencairan DNA bagi HPV 16 adalah pada suhu 
puncak 80.4ºC dan nilai Ct bagi produk spesifik terhadap HPV 16 
adalah pada pusingan ke 20.  Manakala  graf pencairan DNA bagi HPV 
18 adalah pada suhu puncak 79.4ºC dan nilai Ct bagi produk spesifik 
terhadap HPV 18 adalah pada pusingan ke 22.   
 
Sebagai kesimpulan, HPV 16 adalah lebih prevalen, diikuti oleh HPV 
18.  Kajian ini hanya mengesan lima jenis HPV risiko tinggi iaitu HPV 
16, HPV 18, HPV 33, HPV 51 dan HPV 56.  HPV risiko tinggi yang lain 
seperti HPV 31, HPV 35, HPV 39, HPV 45 dan HPV 52, tidak dapat 
dikesan.  Kaedah Tindakbalas Berantai Polimerase-Masa Sebenar 
SyBrGreen mempunyai potensi klinikal dalam penyaringan awal, 
pengesanan dan pengenalpastian jangkitan oleh pelbagai -jenis HPV 
bagi peringkat-peringkat yang berbeza dalam pesakit-pesakit kanser 
servik. 
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temperature of HPV 18 was 79.4ºC, melting 
temperature of primer-dimer was 70ºC. 
 
Amplification plot of multiple infections of HPV 
16 and HPV 18. 
 
Amplification plot of HPV 16, HPV 18 and HPV 
56. 
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 xxiii
LIST OF ABBREVIATIONS 
 
bp 
CIN 
dATP 
dCTP 
dGTP 
DMSO 
DNA 
dNTPs 
dTTP 
ECL 
HCl 
H & E 
HPV 
ISCN 
 
Kbp 
mM 
M 
Min 
ml 
Base pair 
Cervical intraepithelial neoplasia 
Deoxyadenosine triphosphate 
Deoxycytidine triphosphate 
Deoxyguanosine triphasphate 
Dimethylsulfoxide 
Deoxyribonucleic acid 
Deoxynucleotide triphasphate 
Deoxythymidine triphosphate 
Enhanced Chemilluminescent Labelling 
Hidrogen chloride 
Hemotoxylin and Eosin 
Human papillomavirus 
International System for Human Cytogenetic 
Nomenclature. 
Kilo base pair 
Mili mo;ar 
Molarity 
Minute 
Mililitre 
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